US regulatory status: approved. Molecular target: Histamine H1 receptor.
- Target
- Histamine H1 receptor
- Mechanism
- Histamine H1 receptor antagonist
pharma · Chronic Hepatitis B · Recurrent Genital Herpes Simplex Type 2 · ASMB
ASSEMBLY BIOSCIENCES
ASSEMBLY BIOSCIENCES, INC.
ASSEMBLY BIOSCIENCES drug portfolio — 10 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
2 Tower Pl, 7th Floor, South San Francisco, California 94080, US HQ
2014 Founded
99 Employees
Public company Type
ASMB · NYSE Ticker
Company details
- Status
- Public
- HQ
- 2 Tower Pl, 7th Floor, South San Francisco, California 94080, US
- Founded
- 2014
- Employees
- 99
- Programs
- 15
- Drugs
- 10
- Patents
- 14
ASSEMBLY BIOSCIENCES pipeline
Portfolio lens on 10 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
ASSEMBLY BIOSCIENCES drug portfolio — 10 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Drug portfolio
-
-
Development asset linked to ASSEMBLY BIOSCIENCES in public FDA and regional records.
-
Development asset linked to ASSEMBLY BIOSCIENCES in public FDA and regional records. Mechanism: Beta-1 adrenergic receptor antagonist.
- Mechanism
- Beta-1 adrenergic receptor antagonist
-
Development asset linked to ASSEMBLY BIOSCIENCES in public FDA and regional records.
-
Development asset linked to ASSEMBLY BIOSCIENCES in public FDA and regional records.
-
hepatitis b surface antigen
Antiinfectives for systemic use (J07)Antiinfectives for systemic use (J07) compound in ASSEMBLY BIOSCIENCES's portfolio. Molecular target: Surface antigen (HBsAg).
- Target
- Surface antigen (HBsAg)
- Mechanism
- Surface antigen (HBsAg) vaccine antigen
-
Development asset linked to ASSEMBLY BIOSCIENCES in public FDA and regional records.
-
Development asset linked to ASSEMBLY BIOSCIENCES in public FDA and regional records.
-
Development asset linked to ASSEMBLY BIOSCIENCES in public FDA and regional records.
-
Development asset linked to ASSEMBLY BIOSCIENCES in public FDA and regional records.